Literature DB >> 2115077

Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit: a pilot study.

J Schäfer1, H Reichmann.   

Abstract

Primary and secondary carnitine deficiency syndromes are characterized by myopathy, encephalopathy and hepatopathy. We measured plasma levels of free and esterified carnitine in 20 patients from our neurological intensive care unit who required intravenous or tube feeding. After 2-3 weeks 19 patients showed a 30%-60% decrease in the levels of serum free and total carnitine. As soon as oral feeding was recommenced, carnitine levels quickly returned to normal. These data suggest the need for new carnitine-enriched feeding fluids, which are presently under investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115077     DOI: 10.1007/bf00314597

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  An improved and simplified radioisotopic assay for the determination of free and esterified carnitine.

Authors:  J D McGarry; D W Foster
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

2.  Carnitine levels in human serum in health and disease.

Authors:  T Böhmer; A Rydning; H E Solberg
Journal:  Clin Chim Acta       Date:  1974-11-20       Impact factor: 3.786

3.  The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features.

Authors:  G Karpati; S Carpenter; A G Engel; G Watters; J Allen; S Rothman; G Klassen; O A Mamer
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

4.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

6.  Dietary carnitine intake related to skeletal muscle and plasma carnitine concentrations in adult men and women.

Authors:  D L Lennon; E R Shrago; M Madden; F J Nagle; P Hanson
Journal:  Am J Clin Nutr       Date:  1986-02       Impact factor: 7.045

7.  Carnitine balance and effects of intravenous L-carnitine in two patients receiving long-term total parenteral nutrition.

Authors:  L I Worthley; R C Fishlock; A M Snoswell
Journal:  JPEN J Parenter Enteral Nutr       Date:  1984 Nov-Dec       Impact factor: 4.016

8.  Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome.

Authors:  P R Chapoy; C Angelini; W J Brown; J E Stiff; A L Shug; S D Cederbaum
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

9.  Carnitine deficiency with hyperbilirubinemia, generalized skeletal muscle weakness and reactive hypoglycemia in a patient on long-term total parenteral nutrition: treatment with intravenous L-carnitine.

Authors:  L I Worthley; R C Fishlock; A M Snoswell
Journal:  JPEN J Parenter Enteral Nutr       Date:  1983 Mar-Apr       Impact factor: 4.016

10.  A mitochondrial carnitine acylcarnitine translocase system.

Authors:  S V Pande
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  3 in total

1.  Relative carnitine deficiency in autism.

Authors:  Pauline A Filipek; Jenifer Juranek; Minh T Nguyen; Christa Cummings; J Jay Gargus
Journal:  J Autism Dev Disord       Date:  2004-12

2.  Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration.

Authors:  Heyun Kim; Kon Chu; Keun-Hwa Jung; Soon-Tae Lee; Jeong-Min Kim; Sang Kun Lee
Journal:  Neurol Sci       Date:  2012-01-19       Impact factor: 3.307

3.  Valproate encephalopathy and hypocarnitinaemia in diabetic patients.

Authors:  L Averbuch-Heller; T Ben-Hur; A Reches
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.